Authors
Héctor Vázquez-Lorente, Héctor Gil-Vidal, Francesc Calabuig-Montroy, Ángel Domingo-Martínez, Julio Plaza-Diaz, Jordi Salas-Salvadó
Published in
Critical reviews in food science and nutrition. Pages 1-33. Nov 17, 2026. Epub Nov 17, 2026.
Abstract
Dietary inflammatory potential may be associated with sarcopenia, but evidence is heterogeneous. We systematically reviewed associations of the Dietary Inflammatory Index (DII) and energy-adjusted DII (E-DII) with sarcopenia-related outcomes in adults. PubMed, Embase, and Web of Science were searched through 31 August 2026. Random-effects meta-analyses prioritized confirmed sarcopenia. Forty-seven eligible studies were included; 16 contributed to quantitative syntheses and six were prospective. In eight cross-sectional studies, the highest versus lowest DII/E-DII category was associated with greater odds of confirmed sarcopenia (OR = 1.75, 95% CI 1.37-2.24; I2=38.5%; 95% prediction interval 1.03-2.99). Four studies contributed to per-unit analysis (OR = 1.37, 95% CI 1.25-1.51; I2=0%; prediction interval 1.12-1.68). Component-specific evidence extended to muscle strength and physical performance. Exploratory Egger regression indicated funnel-plot asymmetry; trim-and-fill attenuated the primary categorical OR to 1.48 (95% CI 1.24-1.77) and the broad categorical OR to 1.53 (95% CI 1.34-1.76). Certainty was very low. Greater dietary inflammatory potential was associated with confirmed sarcopenia, but predominantly cross-sectional evidence, heterogeneous longitudinal findings, and potential small-study effects limit causal interpretation. Clinical application is premature; prospective cohorts with repeated dietary assessment and standardized outcomes, and intervention trials, are needed.
PMID:
43042601
Bibliographic data and abstract were imported from PubMed on 17 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 12
- Comments 0